XML 23 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total Compass, Inc. Stockholders’ Equity (Deficit)
Non-controlling Interest
Convertible preferred stock
Preferred Stock
2021 Agent Equity Program
2021 Agent Equity Program
Common Stock
2021 Agent Equity Program
Additional Paid-in Capital
2021 Agent Equity Program
Total Compass, Inc. Stockholders’ Equity (Deficit)
Beginning balance (in shares) at Dec. 31, 2020   122,971,900         237,047,550        
Beginning balance at Dec. 31, 2020 $ (862,900,000)   $ 238,000,000.0 $ (1,100,900,000) $ (862,900,000)   $ 1,486,700,000        
Net loss (212,400,000)     (212,400,000) (212,400,000)            
Issuance of common stock upon exercise of stock options (in shares)   4,710,490                  
Issuance of common stock upon exercise of stock options 9,900,000   9,900,000   9,900,000            
Issuance of shares in connection with acquisition (in shares)   249,230                  
Issuance of shares in connection with acquisitions 4,300,000   4,300,000   4,300,000            
Conversion of Series D convertible preferred stock (in shares)   15,920,450         (15,920,450)        
Conversion of Series D convertible preferred stock 67,600,000   67,600,000   67,600,000   $ (67,600,000)        
Vesting of early exercised stock options 1,200,000   1,200,000   1,200,000            
Stock-based compensation 165,000,000.0   165,000,000.0   165,000,000.0            
Ending balance (in shares) at Mar. 31, 2021   143,852,070         221,127,100        
Ending balance at Mar. 31, 2021 (827,300,000)   486,000,000.0 (1,313,300,000) (827,300,000)   $ 1,419,100,000        
Beginning balance (in shares) at Dec. 31, 2021   409,267,751         0        
Beginning balance at Dec. 31, 2021 847,600,000   2,438,800,000 (1,595,000,000) 843,800,000 $ 3,800,000 $ 0        
Net loss $ (188,300,000)     (188,000,000.0) (188,000,000.0) (300,000)          
Issuance of common stock upon exercise of stock options (in shares) 2,594,589 2,594,589                  
Issuance of common stock upon exercise of stock options $ 5,500,000   5,500,000   5,500,000            
Issuance of common stock upon settlement of RSUs, net of taxes withheld (in shares)   1,494,530                  
Issuance of common stock upon settlement of RSUs, net of taxes withheld (7,400,000)   (7,400,000)   (7,400,000)            
Vesting of early exercised stock options 1,100,000   1,100,000   1,100,000            
Issuance of common stock in connection with the 2021 Agent Equity Program (in shares)                 13,608,896    
Issuance of common stock in connection with the 2021 Agent Equity Program               $ 100,000,000.0   $ 100,000,000.0 $ 100,000,000.0
Stock-based compensation 47,000,000.0   47,000,000.0   47,000,000.0            
Ending balance (in shares) at Mar. 31, 2022   426,965,766                  
Ending balance at Mar. 31, 2022 $ 805,500,000   $ 2,585,000,000 $ (1,783,000,000) $ 802,000,000.0 $ 3,500,000